Market Overview: In 2022, the global Asthma and COPD Drugs market reached a size of USD 44.7 Billion, and it is anticipated to attain USD 62.6 Billion by 2032, demonstrating a projected revenue Compound Annual Growth Rate (CAGR) of 4.3% throughout the forecast period. The primary factors driving market growth include an increase in the […]
